In a cohort of 168 resected CRC patients, our group recently demonstrated that PTEN-loss in cancer cells significantly correlates with high levels of tumor-derived IL-8 and low levels of IL-8+ infiltrating mononuclear cells (Conciatori 2020, unpublished data, [103]). The gene discussed is PTEN; the disease is cancer.